Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Humanized or chimeric CD3 antibodies

Humanized or chimeric CD3 antibodies

US Patent 10407501 · Granted Sep 10, 2019

Estimated economic value: $4,295,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of 2025
Antibodies that bind PSMA and gamma-delta T cell receptors2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents binding to EpCAM and CD1372025
Binding agents binding to EpCAM and CD1372025
Antibody variant combinations and uses thereof2025
Antibody variant combinations and uses thereof2025
Agent, uses and methods for treatment2025
Agent, uses and methods for treatment2025
Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use t2025